First Day of Dealings

Avacta Group plc (formerly Readybuy plc) First Day of Dealings on AIM Avacta Group plc ("the Company") announces the re-admission of its existing ordinary shares; the admission of 45,000,000 Placing Shares and the admission of 475,530,102 new Ordinary Shares issued pursuant to the Acquisition Agreement to trading on AIM today. A total of 644,857,446 Ordinary Shares were admitted to trading, giving a market capitalisation for the Company, at the placing price of 2.25p per share, of £14.5m. At the Extraordinary General Meeting of the Company held on Monday 7 August, Daron Lee resigned as a director of the Company; Professor Alastair Smith was appointed Chief Executive and Dr. Gwyn Humphreys, Dr. Simon Webster, Dr. Kurt Baldwin, Tim Sykes, Professor Tony Robards OBE and Alan Aubrey were appointed directors of the Company. Professor Alastair Smith, Chief Executive, Avacta Group plc, commented: "I am delighted that this transaction, leading to our listing on AIM, is on schedule and the funds raised will enable us to focus on the development of our first products. Our relocation to the York Biocentre has been completed successfully with a seamless transition of our laboratories and staff. "Our focus is on delivering multiple revenue streams for shareholders through a range of products and services designed to identify and rapidly analyse substances at the molecular level. Such technology will initially be exploited through applications within the defence, homeland security and biopharmaceutical markets where the need exists for timely analysis of chemicals, viruses, bacteria and proteins such as toxins and antibodies. "We look forward to an exciting year of progress and anticipate regular newsflow concerning product development and planned collaborative agreements" 8th August 2006 Enquiries: Avacta Group plc Tel: 0870 835 4367 Alastair Smith, Chief Executive WH Ireland Limited Tel: 0161 832 2174 David Youngman, Director, Corporate Finance Nexus Financial Ltd Tel: 020 7451 7050 Nicholas Nelson, Director nicholas.nelson@nexusgroup.co.uk In accordance with Schedule Two(g) of the AIM Rules, the Company is pleased to provide the information below:- Director Age Current directorships Previous directorships (last five years) Professor David 39 Avacta Limited Hebden Lodge Hotel Alastair Maclaughlin Company Limited Smith Avacta Analytical Limited TT123 Limited Dr. Simon Webster 38 Avacta Limited None Avacta Analytical Limited Dr. Kurt Justin 38 Avacta Limited None Baldwin Avacta Analytical Limited Dr. Gwynfor Owen 60 Avacta Limited Bradford Particle Design Humphreys Limited Elucidos Limited Nektar Therapeutics UK Connect Yorkshire Limited Inside track I LLP Inside track II LLP Syntopix Group plc Syntopix Services Limited Syntopix Limited Bioniqs Limited Professor Anthony 66 Avacta Limited Bioincubator York Limited William Robards Yorkshire Cancer Research Business Link York and Limited North Yorkshire Limited York and North Yorkshire Knowledge Base (UK) Limited Inward Investment Board Limited Yhman Limited Yorktest Laboratories Yorkshire Building Limited Society Charitable Foundation York Science Park (Innovation Centre) York and North Yorkshire Limited Chamber of Commerce York Science Park Limited White Rose Research Limited York Professional Initiative Yorktest Group Limited Pro-Cure Therapeutics Limited Venturefest (York) Limited Connect Yorkshire LG01 Limited Elucidos Limited Alan John Aubrey 45 Aquarius Equity Partners AXM Venture Capital Limited Limited Axiomlab Empiricom Technologies Limited Axiomlab Limited Energetix Group Limited Axiomlab Group plc Flexisols Limited Axiomlab Investment Management Limited NWSF Holdings Limited Axiomlab Investments Thermetica Limited Limited Inhoco 2835 Limited Inhoco 2895 Limited IP Group Plc Life UK (IP21PO) Limited Modern Biosciences Plc PROACTIS Group Limited PROACTIS Holdings PLC Syntopix Group Plc Syntopix Limited Techtran Corporate Finance Limited Techtran Group Limited Techtran Investments Limited Techtran Limited Techtran Services Limited IP2IPO Limited IP2IPO Management Limited IP2IPO Management II Limited IP Venture Fund (GP) Limited IP Ventures (Scotland) Limited HATT III General Partner Limited Top Technology Ventures Limited TTV IV G.P. Limited Timothy James Sykes 36 Avacta Limited Mountain Warehouse Limited Avacta Analytical Limited Mountain Warehouse Penta Financial Direction Holdings Limited Limited PROACTIS Group Limited PROACTIS Holdings PLC There are no other disclosures required under Schedule Two (g). All terms used in this announcement are defined as set out in the Admission Document dated 13 July 2006.
UK 100

Latest directors dealings